Michael C. Heinrich,
Heikki Joensuu,
George D. Demetri,
Christopher L. Corless,
Jane Apperley,
Jonathan A. Fletcher,
Denis Soulieres,
Stephan Dirnhofer,
Amy Harlow,
Ajia Town,
Arin McKinley,
Shane G. Supple,
John Seymour,
Lilla Di Scala,
Allan van Oosterom,
Richard Herrmann,
Zariana Nikolova,
And Grant McArthur,
- Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases. Heinrich, M.C., Joensuu, H., Demetri, G.D., Corless, C.L., Apperley, J., Fletcher, J.A., Soulieres, D., Dirnhofer, S., Harlow, A., Town, A., McKinley, A., Supple, S.G., Seymour, J., Di Scala, L., van Oosterom, A., Herrmann, R., Nikolova, Z., McArthur, A.G. Clin. Cancer Res. (2008)